Future Demand and Leading Companies Shaping the Biopharmaceutical Fermentation Systems Market to 2029
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What CAGR Is Anticipated for the Biopharmaceutical Fermentation Systems Market Through 2029?
Recently, there has been a marked increase in the market size of biopharmaceutical fermentation systems. The market is expected to expand from $24.61 billion in 2024 to $26.6 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 8.1%. Factors contributing to this growth during the historic period include a rising demand for biologics, supportive regulatory environment, industry consolidation, increased investment in research and development, as well as changes in the healthcare landscape.
The market for biopharmaceutical fermentation systems is predicted to experience significant growth in the coming years, expanding to a size of “$37.73 billion in 2029 with an average annual growth rate (CAGR) of 9.1%.” The projected growth during this period can be credited to the enlargement of the biopharmaceutical pipeline, the shift towards personalized healthcare, the adoption of continuous bioprocessing methods, expansion into emerging markets, and advancements in both automation and digitalization. Major trends for this period are anticipated to include a surge in the adoption of continuous manufacturing practices, growth in the field of personalized medicine, an expanded biosimilars market, utilization of advanced analytics and AI, along with an increased emphasis on sustainability and environmental impact.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15524&type=smp
What Market Forces Are Driving The Biopharmaceutical Fermentation Systems Sector In 2025 And Beyond?
The expansion of the biologics pipeline is projected to fuel the growth of the biopharmaceutical fermentation systems market. Biologics are medicinal products derived from living beings or their components, encompassing vaccines, blood and blood constituents, gene therapies, tissues, and recombinant therapeutic proteins. The growth in the biologics pipeline is due to breakthroughs in biotechnology, deeper comprehension of disease mechanisms, and the need for targeted and personalized treatments. Biopharmaceutical fermentation systems are employed in the production of biologics to nurture genetically modified cells or microorganisms, facilitating the creation of complex therapeutic proteins, antibodies, and vaccines on a large scale. For example, as per the records of the National Library of Medicine, a US-based medical library, in 2023, the Food and Drug Administration (FDA) gave approval for 55 new drugs, comprising 29 new chemical entities (NCEs) and 25 new biological entities (NBEs), which is a 50% increase relative to the 37 approvals in 2022. Hence, the surge in the biologics pipeline is fuelling the growth of the biopharmaceutical fermentation systems market.
The biopharmaceutical fermentation systems market covered in this report is segmented –
1) By Product: Upstream Products, Downstream Products
2) By Application: Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics, Other Applications
3) By End-User: Biopharmaceutical Companies, Contract Manufacturing Organizations, Contract Research Organizations, Academic Research Institutes, Food Industry, Other End-Users
Subsegments:
1) By Upstream Products: Fermenters Or Bioreactors, Culture Media, Inoculum Preparation Systems, Gas And Liquid Flow Control Systems, Process Monitoring And Control Systems, Sterilization Systems
2) By Downstream Products: Filtration Systems, Centrifuges, Chromatography Systems, Ultrafiltration And Microfiltration Systems, Concentration And Purification Systems, Packaging And Storage Systems
Which Emerging Trends And Strategic Shifts Are Shaping The Biopharmaceutical Fermentation Systems Market?
To improve efficiency, scalability, and repeatability, key players in the biologics fermentation systems market are focusing on the creation of cutting-edge fermentation systems like automated bioreactors. These innovative bioprocessing systems incorporate automated control and monitoring technologies to enhance growth conditions for cells or microorganisms involved in biopharmaceutical production. Froilabo, a French laboratory equipment firm, exemplifies this with their launch of completely automated lab-scale bioreactors in October 2022. Built to provide precision and flexibility for a variety of uses including academia, research, process development, and production, these bioreactors ensure top-notch aseptic conditions. Their design allows for customizable options in placing and selecting the type of impeller, and includes a unique magnetic mixer and a non-welded lid.
Which Firms Are Considered Leaders In The Biopharmaceutical Fermentation Systems Market Space?
Major companies operating in the biopharmaceutical fermentation systems market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., 3M Company, Danaher Corporation, Merck KGaA, Becton Dickinson and Company, GE Healthcare, Agilent Technologies Inc., Lonza Group AG, GEA Group AG, Sartorius Stedim Biotech, Bio-Rad Laboratories Inc., Pall Corporation, Nova Biomedical, Eppendorf AG, Repligen Corporation, ZETA Holding GmbH, New Brunswick Scientific, ABEC Inc., Pierre Guérin Technologies, AntoXa Corporation, Applikon Biotechnology, Cellexus Ltd., Infors HT, BioPharm Process Associates LLC
What Role Do Regional Policies And Investments Play In Biopharmaceutical Fermentation Systems Market Expansion?
North America was the largest region in the biopharmaceutical fermentation systems market in 2024. The regions covered in the biopharmaceutical fermentation systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=15524&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
